Last reviewed · How we verify

NCT04302961

Effects of Gait Retraining With Auditory Feedback

Completed EARLY_PHASE1 Last updated 19 August 2024
What this trial tests

EARLY_PHASE1 trial testing Auditory Feedback in Ankle Injuries in 28 participants. Completed in 30 June 2021.

Timeline
5 October 2020
Primary endpoint
30 June 2021
30 June 2021

Quick facts

Lead sponsorUniversity of North Carolina, Charlotte
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment28
Start date5 October 2020
Primary completion30 June 2021
Estimated completion30 June 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of North Carolina, Charlotte

Who can join

Adults 18 to 40, any sex, with Ankle Injuries or Ankle Inversion Sprain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is evidence to support individuals with chronic ankle instability (CAI) have altered gait biomechanics which may lead to re-injury and poor patient outcomes. Currently, there are no interventions specifically targeting these abnormal gait biomechanics. Evidence supports the use of an external focus of attention feedback to promote motor learning and retention. The overall purpose of randomized clinical trial is to determine the effects of a 2-week (8 session) gait retraining protocol using an auditory external feedback instrument can (1) alter biomechanics during functional tasks (walking, step-down, lunge, lateral hops, and balance) (2) improve ankle cartilage measures and (3) improve patient-reported outcome measures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ankle Injuries

Currently open trials in the same condition.

Other University of North Carolina, Charlotte trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04302961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing